Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 7/20 | 0.49 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6835834 | 0.84 | ALB (0.64) | ALBALDH1A1MEN1POLBKMT2A | |
| SCHEMBL6833800 | 0.83 | ALB (0.49) | ALBABCC1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL6833427 | 0.83 | ALB (0.50) | ALBMEN1KMT2ARAB9ANPC1 | |
| SCHEMBL6713278 | 0.82 | HSD17B10 (0.38) | ALBTSHRKDM4EALDH1A1HSD17B10 | |
| SCHEMBL6707964 | 0.81 | HSD17B10 (0.37) | TSHRKDM4EALDH1A1HSD17B10MEN1 | |
| SCHEMBL6833763 | 0.81 | ALB (0.39) | ALBMEN1KMT2A | |
| SCHEMBL3253062 | 0.81 | KDM4E (0.57) | ABCC1TSHRKDM4EALDH1A1HSD17B10 | |
| SCHEMBL6833985 | 0.81 | ALB (0.42) | ALBALDH1A1MEN1KMT2A | |
| SCHEMBL6834424 | 0.81 | ALB (0.43) | ALBTSHRMEN1KMT2A | |
| SCHEMBL6830635 | 0.80 | ALB (0.41) | ALBTSHRMEN1KMT2ACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ALB 1417/4885ABCC1 2452/4885TSHR 3622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.